NasdaqGS - Delayed Quote USD
BioAge Labs, Inc. (BIOA)
4.4500
+0.0100
+(0.23%)
At close: June 6 at 4:00:01 PM EDT
4.6799
+0.23
+(5.17%)
After hours: June 6 at 7:23:03 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 1.3M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
PANDE VIJAY SATYANAND PH.D. Director | Purchase at price 19.73 - 19.90 per share. | Indirect | 4,329,019 | Oct 3, 2024 |
ENRIGHT PATRICK G. Director | Purchase at price 18.00 per share. | Indirect | 7,200,000 | Sep 27, 2024 |
ENRIGHT PATRICK G. Director | -- | Indirect | -- | Sep 27, 2024 |
CORMORANT ASSET MANAGEMENT ,L.P Unknown | Purchase at price 18.00 per share. | Indirect | 8,100,000 | Sep 27, 2024 |
CORMORANT ASSET MANAGEMENT ,L.P Unknown | -- | Indirect | -- | Sep 27, 2024 |
HEMRAJANI REKHA Director | Purchase at price 18.00 per share. | Direct | 54,000 | Sep 27, 2024 |
HEALY JAMES I Director | Purchase at price 18.00 per share. | Indirect | 11,999,970 | Sep 27, 2024 |
HEALY JAMES I Director | -- | Indirect | -- | Sep 27, 2024 |
BARTON SHANE Officer | Purchase at price 18.00 per share. | Direct | 47,376 | Sep 27, 2024 |
PANDE VIJAY SATYANAND PH.D. Director | Purchase at price 18.00 per share. | Indirect | 16,200,000 | Sep 27, 2024 |
PANDE VIJAY SATYANAND PH.D. Director | -- | Indirect | -- | Sep 27, 2024 |
Related Tickers
EVT.DE Evotec SE
7.06
+0.94%
PRFX PainReform Ltd.
2.0600
+4.57%
AGY.L Allergy Therapeutics plc
6.80
-8.11%
LFCR Lifecore Biomedical, Inc.
6.85
+1.48%
CPIX Cumberland Pharmaceuticals Inc.
5.82
+7.92%
EVO Evotec SE
4.0500
+1.00%
RDHL RedHill Biopharma Ltd.
1.9900
+3.11%
ALVO Alvotech
10.66
+1.52%
BFRI Biofrontera Inc.
0.6000
+0.08%
ANG.BO ANG Lifesciences India Limited
29.77
+1.99%